ertapenem has been researched along with Necrotizing Pyelonephritis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Critchley, IA; Dane, A; Eckburg, PB; Jain, A; Keutzer, T; Kwak, H; Melnick, D; Moore, G; Muir, L; Phelan, AM; Talley, AK; Walpole, S | 1 |
| Akinapelli, K; Aronin, SI; Breen, J; Das, AF; Dunne, MW; Puttagunta, S; Zelasky, MT | 1 |
| Kiertiburanakul, S; Malaisri, C; Phuphuakrat, A; Santanirand, P; Wibulpolprasert, A | 1 |
| Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK | 1 |
| Frasquet-Artes, J; Garrido-Jareño, M; López-Hontangas, JL; Tasias-Pitarch, M | 1 |
| Ersoy, F; Uslu, H; Yılmaz, F | 1 |
| Kim, JH; Kim, MJ; Sohn, JW; Yang, KS; Yoon, YK | 1 |
| Bayraktar, B; Dalgic, N; Dincer, E; Pelit, S; Sancar, M | 1 |
| Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N | 1 |
| Chung, MH; Kim, HY; Kim, JY; Kim, MJ; Lee, JS; Lee, MS; Park, DW; Park, YS; Peck, KR; Yeom, JS | 1 |
| Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O | 1 |
| Gesser, RM; Jiang, Q; Wells, WG; Woods, GL | 1 |
1 review(s) available for ertapenem and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
First case of renal abscess by Parvimonas micra.
Topics: Abdominal Abscess; Aged; Anti-Bacterial Agents; Bacteremia; Clindamycin; Dental Plaque; Early Diagnosis; Ertapenem; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Opportunistic Infections; Postoperative Complications; Pyelonephritis; Tooth Extraction | 2019 |
5 trial(s) available for ertapenem and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Carbapenems; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Pyelonephritis; Urinary Tract Infections | 2022 |
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.
Topics: Adult; Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Ertapenem; Humans; Pyelonephritis; Urinary Tract Infections | 2023 |
A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pilot Projects; Pyelonephritis | 2017 |
Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Ertapenem; Humans; Odds Ratio; Pyelonephritis; Republic of Korea; Risk Factors; Urinary Tract Infections | 2012 |
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Administration Schedule; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Male; Middle Aged; Multicenter Studies as Topic; Pyelonephritis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections | 2004 |
6 other study(ies) available for ertapenem and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Ertapenem Associated With Seizures in Treatment of Pyelonephritis in a Chronic Peritoneal Dialysis Patient.
Topics: Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Drug Dosage Calculations; Ertapenem; Escherichia coli; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pyelonephritis; Seizures | 2016 |
Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Republic of Korea; Retrospective Studies; Survival Analysis; Treatment Failure; Young Adult | 2017 |
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Follow-Up Studies; Hospitals; Humans; Infant; Male; Pyelonephritis; Recurrence; Retrospective Studies; Turkey; Urinary Tract Infections | 2011 |
New Delhi metallo-beta-lactamase from traveler returning to Canada.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine | 2011 |
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors | 2012 |